Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublocade vs Suboxone in Pregnant Women with OUD
NCT04212065Phase 4Withdrawn
- Sponsor
- The Ohio State University
- Start
- Feb 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by The Ohio State University. Planned start Feb 2020; status: withdrawn.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04212065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04212065.